Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve the audited financial results ....
MEDICAMEQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Medicamen Biotech has informed BSE about a board meeting scheduled for May 27, 2026 to consider and approve the audited financial results for Q4 and FY ended March 31, 2026. The meeting will also discuss final dividend recommendation for FY 2025-26, though no specific amount is mentioned. Additionally, the board will consider appointing SPB & Co as Cost Auditor and Cheena & Associates as Internal Auditor for FY 2026-27. The trading window remains closed until 48 hours after the results are declared.
This is a routine meeting intimation with no specific financial data or red flags. Investors should note the trading window closure and await the actual results announcement on May 27, 2026. Any dividend decision will be known only after the meeting.